Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics

Archives of Neurology

Volumn 56, Issue 5, 1999, Pages 540-547

  Wolfe, Gil I ^a   Baker, Noel S ^a   Amato, Anthony A ^b   Jackson, Carlayne E ^b   Nations, Sharon P ^a   Saperstein, David S ^a   Cha, Choon H ^a   Katz, Jonathan S ^a   Bryan, Wilson W ^a   Barohn, Richard J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PARESTHESIA; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY; SKIN TINGLING;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; NEURAL CONDUCTION; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0032939765     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.5.540     Document Type: Article

References (43)

1. Beghi E, Monticelli ML, and the Italian General Practitioner Study Group. Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions, I: prevalence and general characteristics of the sample. Neurology. 1995;45:1832-1836.
2. Matthews WB. Cryptogenic polyneuritis. Proc R Soc Med. 1952;45:667-669.
3. Rose FC. Peripheral neuropathy. Proc R Soc Med. 1960;53:51-53.
4. Fagius J. Chronic cryptogenic polyneuropathy: the search for a cause. Acta Neurol Scand. 1983;67:173-180.
5. McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry. 1984;47:530-535.
6. Grahmann F, Winterholler M, Neundörfer B. Cryptogenic polyneuropathies: an out-patient follow-up study. Acta Neurol Scand. 1991;84:221-225.
7. Hopf HC, Althaus HH, Vogel P. An evaluation of the course of peripheral neuropathies based or clinical and neurographical re-examinations. Eur Neurol. 1973; 9:90-104.
8. Corvisier N, Vallat JM, Hugon J, Lubeau M, Dumas M. Les neuropathies de cause indéterminée. Rev Neurol (Paris). 1987;143:279-283.
9. Notermans NC, Wokke JHJ, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry. 1993;56:1066-1071.
10. Notermans NC, Wokke JHJ, van der Graaf Y, et al. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry. 1994;57:1525-1527.
11. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology. 1993;43:1508-1512.
12. Yarnitsky D. Quantitative sensory testing. Muscle Nerve. 1997;20:198-204.
13. Dyck PJ, Karnes J, O'Brien PC, Zimmerman IR. Detection thresholds of cutaneous sensation in humans. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral Neuropathy. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1993:706-728.
14. Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991; 41:617-618.
15. Wilbourn AJ. Diabetic neuropathies. In: Brown WF, Bolton CF, eds. Clinical Electromyography. 2nd ed. Boston, Mass: Butterworth-Heinemann: 1993:477-515.
16. Periquet MI, Kissel J, Collins M, et al. A prospective study of painful sensory neuropathies [abstract]. Neurology. 1997;48:A186-A187.
17. Gorson KC, Ropper AH. Idiopathic distal small fiber neuropathy. Acta Neurol Scand. 1995;92:376-382.
18. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.
19. Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-862.
20. Prineas J. Polyneuropathies of undetermined cause. Acta Neurol Scand Suppl. 1970;44:1-72.
21. Notermans NC, Wokke JHJ, van den Berg LH, et al. Chronic idiopathic axonal polyneuropathy: comparison of patients with and without monoclonal gammopathy. Brain. 1996;119:421-427.
22. Kyle RA. "Benign" monoclonal gammopathy: a misnomer. JAMA. 1984;251: 1849-1854.
23. Notermans NC, Wokke JHJ, Lokhorst HM, et al. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. Brain. 1994;117:1385-1393.
24. Pestronk A, Li F, Griffin J, et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology. 1991; 41:357-362.
25. Nemni R, Fazio R, Quattrini A, et al. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol. 1993; 43:79-86.
26. Slogosky SL, Chavin JM, Heiman-Patterson T, Tahmoush AJ. Idiopathic axonal neuropathy responsive to immunosuppression [abstract]. Ann Neurol. 1995;38: 336.
27. Lopate G, Parks BJ, Goldstein JM, et al. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry. 1997;62:581-585.
28. Holland NR, Stocks A, Hauer P, et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology. 1997;48:708-711.
29. Mendell JR, Periquet I, Kissel JT, et al. Distal painful axonal idiopathic neuropathy: criteria for diagnosis and distinction from other sensory neuropathies [abstract]. Neurology. 1998;50:A343-A344.
30. Holland NR, Crawford TO, Hauer P, et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol. 1998;44:47-59.
31. Light AR, Perl ER. Peripheral sensory systems. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral Neuropathy. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1993:149-165.
32. Dyck PJ, Bushek W, Spring EM, et al. Vibratory and cooling detection thresholds compared with other tests diagnosing and staging diabetic neuropathy. Diabetes Care. 1987;10:432-440.
33. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229-239.
34. Jamal GA, Hansen S, Weir AI, Ballantyne JP. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve. 1987;10:537-545.
35. Smith SJM, Ali Z, Fowler CJ. Cutaneous thermal thresholds in patients with painful burning feet. J Neurol Neurosurg Psychiatry. 1991;54:877-881.
36. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995;45(suppl 9):S17-S25.
37. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: current concepts of treatment. Ann Pharmacother. 1995;29:769-777.
38. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology. 1997;48:1467.
39. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12:56-58.
40. Segal AZ, Rordorf G. Gabapentin as novel treatment for posttherapeutic neuralgia. Neurology. 1996;46:1175-1176.
41. Dallocchio C, Buffa C, Ligure N, Mazzarello P, Chiroli S. Gabapentin versus amitriptyline in painful diabetic neuropathy of the elderly [abstract]. Neurology. 1998; 50:A102-A103.
42. Edwards KR, Hes MS, LaMoreaux LK, Garofalo EA, Koto EM. Gabapentin (Neurontin) for pain associated with diabetic peripheral neuropathy: a double-blind, placebo-controlled study [abstract]. Neurology. 1998;50:A378-A379.
43. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther. 1977;22:196-199.